P. Jacoulet

1.2k total citations
53 papers, 823 citations indexed

About

P. Jacoulet is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, P. Jacoulet has authored 53 papers receiving a total of 823 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 29 papers in Pulmonary and Respiratory Medicine and 10 papers in Surgery. Recurrent topics in P. Jacoulet's work include Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Research Studies (15 papers) and Lung Cancer Diagnosis and Treatment (10 papers). P. Jacoulet is often cited by papers focused on Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Research Studies (15 papers) and Lung Cancer Diagnosis and Treatment (10 papers). P. Jacoulet collaborates with scholars based in France, United States and Thailand. P. Jacoulet's co-authors include A Depierre, É. Lemarié, G Dabouis, Virginie Westeel, J.C. Dalphin, D. Pernet, A. Dubiez, J.‐C. Dalphin, Agathe Bajard and Jean-Luc Breton and has published in prestigious journals such as Journal of Clinical Oncology, European Heart Journal and British Journal of Cancer.

In The Last Decade

P. Jacoulet

52 papers receiving 799 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Jacoulet France 13 577 481 147 103 93 53 823
Yosuke Kawashima Japan 11 605 1.0× 339 0.7× 77 0.5× 74 0.7× 53 0.6× 41 721
Junxun Ma China 18 596 1.0× 373 0.8× 124 0.8× 55 0.5× 95 1.0× 45 796
Nathalie Théou–Anton France 14 362 0.6× 322 0.7× 127 0.9× 138 1.3× 79 0.8× 28 666
Amaury Daste France 13 610 1.1× 279 0.6× 129 0.9× 69 0.7× 167 1.8× 66 848
Jun Sugisaka Japan 8 602 1.0× 287 0.6× 82 0.6× 51 0.5× 50 0.5× 20 680
Mario R. Velasco United States 13 406 0.7× 162 0.3× 130 0.9× 48 0.5× 124 1.3× 23 646
Audrey Simonaggio France 10 445 0.8× 278 0.6× 104 0.7× 45 0.4× 48 0.5× 23 567
Jose M. Pacheco United States 16 591 1.0× 485 1.0× 196 1.3× 97 0.9× 46 0.5× 39 800
Mary Kate Kasler United States 6 620 1.1× 191 0.4× 76 0.5× 135 1.3× 60 0.6× 8 713
J.M. Sánchez-Torres Spain 13 614 1.1× 428 0.9× 150 1.0× 39 0.4× 43 0.5× 21 772

Countries citing papers authored by P. Jacoulet

Since Specialization
Citations

This map shows the geographic impact of P. Jacoulet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Jacoulet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Jacoulet more than expected).

Fields of papers citing papers by P. Jacoulet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Jacoulet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Jacoulet. The network helps show where P. Jacoulet may publish in the future.

Co-authorship network of co-authors of P. Jacoulet

This figure shows the co-authorship network connecting the top 25 collaborators of P. Jacoulet. A scholar is included among the top collaborators of P. Jacoulet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Jacoulet. P. Jacoulet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eberst, Guillaume, Déwi Vernerey, Caroline Laheurte, et al.. (2022). Prognostic value of CD4+ T lymphopenia in non-small cell lung Cancer. BMC Cancer. 22(1). 529–529. 17 indexed citations
2.
Laheurte, Caroline, Magalie Dosset, Déwi Vernerey, et al.. (2019). Distinct prognostic value of circulating anti-telomerase CD4+ Th1 immunity and exhausted PD-1+/TIM-3+ T cells in lung cancer. British Journal of Cancer. 121(5). 405–416. 67 indexed citations
3.
Monnet, Élisabeth, P. Jacoulet, Pierre‐Emmanuel Falcoz, et al.. (2019). Let us not underestimate the long-term risk of SPLC after surgical resection of NSCLC. Lung Cancer. 137. 23–30. 19 indexed citations
4.
Manzoni, P., P. Jacoulet, D. Pernet, et al.. (2011). [Bevacizumab and lung cancer: eligible patients in daily practice].. Translational Oncology. 28(1). 25–31. 2 indexed citations
5.
Manzoni, P., P. Jacoulet, D. Pernet, et al.. (2011). Bévacizumab et cancer bronchique : population cible en pratique quotidienne. Revue des Maladies Respiratoires. 28(1). 25–31. 2 indexed citations
6.
Girard, Nicolas, P. Jacoulet, D. Pernet, et al.. (2009). Third-Line Chemotherapy in Advanced Non-small Cell Lung Cancer: Identifying the Candidates for Routine Practice. Journal of Thoracic Oncology. 4(12). 1544–1549. 56 indexed citations
7.
Jacoulet, P., et al.. (2009). Fracture isolée de l’os trapézoïde : à propos d’un cas. Chirurgie de la Main. 28(6). 378–380. 6 indexed citations
8.
Breton, Jean-Luc, David Braun, Élisabeth Quoix, et al.. (2006). Long-duration, weekly treatment with gemcitabine plus vinorelbine for non-small cell lung cancer: A multicenter phase II study. Lung Cancer. 51(3). 347–355. 4 indexed citations
9.
Jacoulet, P.. (2004). Résultats de la prothèse trapézométacarpienne ARPE™ : à propos de 37 implantations. Chirurgie de la Main. 24(1). 24–28. 32 indexed citations
10.
Bajard, Agathe, Virginie Westeel, A. Dubiez, et al.. (2004). Multivariate analysis of factors predictive of brain metastases in localised non-small cell lung carcinoma. Lung Cancer. 45(3). 317–323. 102 indexed citations
11.
Jacoulet, P., et al.. (2004). Mésothéliome pleural malin. Revue des Maladies Respiratoires. 21(1). 180–181. 3 indexed citations
12.
Depierre, A, Virginie Westeel, & P. Jacoulet. (2001). Preoperative chemotherapy for non-small cell lung cancer. Cancer Treatment Reviews. 27(2). 119–127. 8 indexed citations
13.
Quoix, Élisabeth, Jean-Luc Breton, Casey L. Daniel, et al.. (2001). Etoposide phosphate with carboplatin in the treatment of elderly patients with small-cell lung cancer: A phase II study. Annals of Oncology. 12(7). 957–962. 38 indexed citations
14.
Mennecier, B., P. Jacoulet, A. Dubiez, et al.. (2000). Concurrent cisplatin/etoposide chemotherapy plus twice daily thoracic radiotherapy in limited stage small cell lung cancer: a phase II study. Lung Cancer. 27(3). 137–143. 7 indexed citations
15.
Jacoulet, P., et al.. (1995). Phase I study of vinorelbine and carboplatin in advanced non-small cell lung cancer. Lung Cancer. 12(3). 247–257. 12 indexed citations
16.
Jacoulet, P.. (1994). Double syndrome canalaire au membre supérieur par tophi goutteux. Annales de Chirurgie de la Main et du Membre Supérieur. 13(1). 42–45. 7 indexed citations
17.
Depierre, A, et al.. (1991). A Phase II Study of Navelbine (Vinorelbine) in the Treatment of Non-Small-Cell Lung Cancer. American Journal of Clinical Oncology. 14(2). 115–119. 223 indexed citations
18.
Bernard, Yvette, et al.. (1990). Aortie valve area evolution after percutaneous aortic valvuloplasty. European Heart Journal. 11(2). 98–107. 4 indexed citations
19.
Depierre, A, et al.. (1989). Efficacy of Navelbine (NVB) in non-small cell lung cancer (NSCLC).. PubMed. 16(2 Suppl 4). 26–9. 42 indexed citations
20.
Toussaint, B., et al.. (1989). Lésions par blast de la première commissure. Annales de Chirurgie de la Main. 8(4). 338–343. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026